Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders

US Patent 9255095 · Granted Feb 9, 2016

Estimated economic value: $4,766,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide,2025
Compounds and pharmaceutical compositions thereof for the treatment of diseases2024
5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2023
Compounds and pharmaceutical compositions thereof for the treatment of diseases2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the2022
Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the2022
5-[(piperazin-l-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS 2021
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMT2020
5-[3-[piperazin-1-yl]-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMT2020